Nav: Home

No proof that radiation from X rays and CT scans causes cancer

February 03, 2016

MAYWOOD, Il. - The widespread belief that radiation from X rays, CT scans and other medical imaging can cause cancer is based on an unproven, decades-old theoretical model, according to a study published in the American Journal of Clinical Oncology.

The model, known as linear no-threshold (LNT), is used to estimate cancer risks from low-dose radiation such as medical imaging. But risk estimates based on this model "are only theoretical and, as yet, have never been conclusively demonstrated by empirical evidence," corresponding author James Welsh, MD and colleagues write. Use of the LNT model drives unfounded fears and "excessive expenditures on putative but unneeded and wasteful safety measures."

Dr. Welsh is a Loyola University Medical Center radiation oncologist and a professor in the Department of Radiation Oncology of Loyola University Chicago Stritch School of Medicine.

The LNT model dissuades many physicians from using appropriate imaging techniques and "discourages many in the public from getting proper and needed imaging, all in the name of avoiding any radiation exposure," Dr. Welsh and colleagues write.

The authors reexamined the original studies, dating back more than 70 years, which led to adoption of the LNT model. This reappraisal found that the data reported in those studies do not actually support the LNT model.

In the LNT model, the well-established cancer-causing effects of high doses of radiation are extended downward in a straight line to very low doses. The LNT model assumes there is no safe dose of radiation, no matter how small. However, the human body has evolved the ability to repair damage from low-dose radiation that naturally occurs in the environment.

The LNT model dates to studies, conducted in the 1940s, of fruit flies exposed to various doses of radiation. The scientists who conducted those studies concluded there is no safe level of radiation, thus giving rise to the LNT model that is used to this day. But their conclusion was unwarranted because their experiments had not been done at truly low doses. A study exposing fruit flies to low-dose radiation wasn't conducted until 2009, and this study did not support the LNT model.

Studies of atomic bomb survivors and other epidemiological studies of human populations have never conclusively demonstrated that low-dose radiation exposure can cause cancer.

Any claim that low-dose radiation from medical imaging procedures is known to cause cancer "should be vigorously challenged, because it serves to alarm and perhaps harm, rather than educate," Dr. Welsh and colleagues write.

The authors conclude the LNT model "should finally and decisively be abandoned."

The study is titled "The birth of the illegitimate linear no-threshold model - an invalid paradigm for estimating risk following low-dose radiation exposure."

In addition to Dr. Welsh, co-authors are Jeffry Siegel, PhD, president and CEO of Nuclear Physics Enterprises (first author); Charles Pennington of NAC International and Bill Sacks, MD, PhD, emeritus medical officer in the FDA Center for Devices and Radiological Health.
-end-


Loyola University Health System

Related Cancer Articles:

Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Cancer genomics continued: Triple negative breast cancer and cancer immunotherapy
Continuing PLOS Medicine's special issue on cancer genomics, Christos Hatzis of Yale University, New Haven, Conn., USA and colleagues describe a new subtype of triple negative breast cancer that may be more amenable to treatment than other cases of this difficult-to-treat disease.
Metabolite that promotes cancer cell transformation and colorectal cancer spread identified
Osaka University researchers revealed that the metabolite D-2-hydroxyglurate (D-2HG) promotes epithelial-mesenchymal transition of colorectal cancer cells, leading them to develop features of lower adherence to neighboring cells, increased invasiveness, and greater likelihood of metastatic spread.
UH Cancer Center researcher finds new driver of an aggressive form of brain cancer
University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age.
UH Cancer Center researchers develop algorithm to find precise cancer treatments
University of Hawai'i Cancer Center researchers developed a computational algorithm to analyze 'Big Data' obtained from tumor samples to better understand and treat cancer.
New analytical technology to quantify anti-cancer drugs inside cancer cells
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond.
Radiotherapy for lung cancer patients is linked to increased risk of non-cancer deaths
Researchers have found that treating patients who have early stage non-small cell lung cancer with a type of radiotherapy called stereotactic body radiation therapy is associated with a small but increased risk of death from causes other than cancer.
Cancer expert says public health and prevention measures are key to defeating cancer
Is investment in research to develop new treatments the best approach to controlling cancer?
UI Cancer Center, Governors State to address cancer disparities in south suburbs
The University of Illinois Cancer Center and Governors State University have received a joint four-year, $1.5 million grant from the National Cancer Institute to help both institutions conduct community-based research to reduce cancer-related health disparities in Chicago's south suburbs.
Leading cancer research organizations to host international cancer immunotherapy conference
The Cancer Research Institute, the Association for Cancer Immunotherapy, the European Academy of Tumor Immunology, and the American Association for Cancer Research will join forces to sponsor the first International Cancer Immunotherapy Conference at the Sheraton New York Times Square Hotel in New York, Sept.

Related Cancer Reading:

The Emperor of All Maladies: A Biography of Cancer
by Siddhartha Mukherjee (Author)

The Truth about Cancer: What You Need to Know about Cancer's History, Treatment, and Prevention
by Ty M. Bollinger (Author)

Chris Beat Cancer: A Comprehensive Plan for Healing Naturally
by Chris Wark (Author)

The Cancer-Fighting Kitchen, Second Edition: Nourishing, Big-Flavor Recipes for Cancer Treatment and Recovery
by Rebecca Katz (Author), Mat Edelson (Author)

Anticancer: A New Way of Life
by David Servan-Schreiber MD PhD (Author)

F*ck Cancer: A totally inappropriate self-affirming adult coloring book (Totally Inappropriate Series) (Volume 4)
by Jen Meyers (Author)

The Breakthrough: Immunotherapy and the Race to Cure Cancer
by Charles Graeber (Author)

The Biology of Cancer, 2nd Edition
by Robert A. Weinberg (Author)

Physicians' Cancer Chemotherapy Drug Manual 2019
by Edward Chu (Author), Vincent T. DeVita Jr. (Author)

Cancer: Step Outside the Box
by Ty M. Bollinger (Author)

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Approaching With Kindness
We often forget to say the words "thank you." But can those two words change how you — and those around you — look at the world? This hour, TED speakers on the power of gratitude and appreciation. Guests include author AJ Jacobs, author and former baseball player Mike Robbins, Dr. Laura Trice, Professor of Management Christine Porath, and former Danish politician Özlem Cekic.
Now Playing: Science for the People

#509 Anisogamy: The Beginning of Male and Female
This week we discuss how the sperm and egg came to be, and how a difference of reproductive interest has led to sexual conflict in bed bugs. We'll be speaking with Dr. Geoff Parker, an evolutionary biologist credited with developing a theory to explain the evolution of two sexes, about anisogamy, sexual reproduction through the fusion of two different gametes: the egg and the sperm. Then we'll speak with Dr. Roberto Pereira, research scientist in urban entomology at the University of Florida, about traumatic insemination in bed bugs.